Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel

During the long-term evolution of animal toxins acting on potassium channels, the acidic residues can orientate the toxin binding interfaces by adjusting the molecular polarity. Based on the evolutionary function of toxin acidic residues, de novo peptide drugs with distinct binding interfaces were designed for the immunotherapeutic target, the Kv1.3 channel. Using a natural basic toxin, BmKTX, as a template, which contains 2 acidic residues (Asp19 and Asp33), we engineered two new peptides BmKTX-19 with 1 acidic residue (Asp33), and BmKTX-196 with 2 acidic residues (Asp6 and Asp33) through only adjusting acidic residue distribution for reorientation of BmKTX binding interface. Pharmacological experiments indicated that BmKTX-19 and BmKTX-196 peptides were specific inhibitors of the Kv1.3 channel and effectively suppressed cytokine secretion. In addition to the structural similarity between the designed and native peptides, both experimental alanine-scanning mutagenesis and computational simulation further indicated that the binding interface of wild-type BmKTX was successfully reoriented in BmKTX-19 and BmKTX-196, which adopted distinct toxin surfaces as binding interfaces. Together, these findings indicate not only the promising prospect of BmKTX-19 and BmKTX-196 as drug candidates but also the desirable feasibility of the evolution-guided peptide drug design for discovering numerous peptide drugs for the Kv1.3 channel.

[1]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[2]  Yingliang Wu,et al.  Two Conserved Arginine Residues from the SK3 Potassium Channel Outer Vestibule Control Selectivity of Recognition by Scorpion Toxins* , 2013, The Journal of Biological Chemistry.

[3]  Hui Liu,et al.  Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels. , 2008, Journal of proteome research.

[4]  Michel De Waard,et al.  Diversity of folds in animal toxins acting on ion channels. , 2004, The Biochemical journal.

[5]  Hui Liu,et al.  The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods , 2013, Nature Communications.

[6]  H Oschkinat,et al.  Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the pleckstrin homology domain from beta-spectrin. , 1997, Journal of molecular biology.

[7]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[8]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[9]  Y. Rosenstein,et al.  Vm 24 , a Natural Immunosuppressive Peptide , Potently and Selectively Blocks Kv 1 . 3 Potassium Channels of Human T Cells , 2012 .

[10]  E Blanc,et al.  Solution structure of BmKTX, a K+ blocker toxin from the Chinese scorpion Buthus Martensi , 2000, Proteins.

[11]  Brian J. Smith,et al.  Engineering a Stable and Selective Peptide Blocker of the Kv1.3 Channel in T Lymphocytes , 2009, Molecular Pharmacology.

[12]  N. Andreotti,et al.  Animal toxins acting on voltage-gated potassium channels. , 2008, Current pharmaceutical design.

[13]  Michael Nilges,et al.  ARIA2: Automated NOE assignment and data integration in NMR structure calculation , 2007, Bioinform..

[14]  Ling Jin,et al.  Molecular Mechanism of the Sea Anemone Toxin ShK Recognizing the Kv1.3 Channel Explored by Docking and Molecular Dynamic Simulations , 2007, J. Chem. Inf. Model..

[15]  K. Chandy,et al.  Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease , 2012, Journal of Pharmacology and Experimental Therapeutics.

[16]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[17]  E. Campbell,et al.  Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K+ channel , 2013, eLife.

[18]  Huan-Xiang Zhou,et al.  Electrostatic recognition and induced fit in the kappa-PVIIA toxin binding to Shaker potassium channel. , 2005, Journal of the American Chemical Society.

[19]  H. Wulff,et al.  Design of PAP-1, a Selective Small Molecule Kv1.3 Blocker, for the Suppression of Effector Memory T Cells in Autoimmune Diseases , 2005, Molecular Pharmacology.

[20]  Yingliang Wu,et al.  Selective Inhibition of CCR7− Effector Memory T Cell Activation by a Novel Peptide Targeting Kv1.3 Channel in a Rat Experimental Autoimmune Encephalomyelitis Model* , 2012, The Journal of Biological Chemistry.

[21]  Y. Rosenstein,et al.  Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells , 2012, Molecular Pharmacology.

[22]  M. Biancalana,et al.  A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library , 2009, Proceedings of the National Academy of Sciences.

[23]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[24]  Z. Cao,et al.  BF9, the First Functionally Characterized Snake Toxin Peptide with Kunitz‐Type Protease and Potassium Channel Inhibiting Properties , 2014, Journal of biochemical and molecular toxicology.

[25]  Su Qiu,et al.  Protein-protein recognition control by modulating electrostatic interactions. , 2010, Journal of proteome research.

[26]  Yingliang Wu,et al.  Open conformation of hERG channel turrets revealed by a specific scorpion toxin BmKKx2 , 2014, Cell & Bioscience.

[27]  K. Chandy,et al.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases. , 2012, Toxicon : official journal of the International Society on Toxinology.

[28]  I. Huys,et al.  A novel conotoxin inhibiting vertebrate voltage-sensitive potassium channels. , 2003, Toxicon : official journal of the International Society on Toxinology.

[29]  R. Norton,et al.  A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases , 2014, Scientific Reports.

[30]  Z. Cao,et al.  Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues. , 2014, Biochemical and biophysical research communications.

[31]  P. Hotez,et al.  Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Hui Liu,et al.  Structural Basis of a Potent Peptide Inhibitor Designed for Kv1.3 Channel, a Therapeutic Target of Autoimmune Disease* , 2008, Journal of Biological Chemistry.

[33]  Yingliang Wu,et al.  Hg1, Novel Peptide Inhibitor Specific for Kv1.3 Channels from First Scorpion Kunitz-type Potassium Channel Toxin Family* , 2012, The Journal of Biological Chemistry.

[34]  A. Brunger.  Version 1.2 of the Crystallography and NMR system , 2007, Nature Protocols.

[35]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.

[36]  R. C. Rodríguez de la Vega,et al.  Mining on scorpion venom biodiversity. , 2010, Toxicon : official journal of the International Society on Toxinology.

[37]  A. Ménez,et al.  Mapping the Functional Anatomy of BgK on Kv1.1, Kv1.2, and Kv1.3 , 1999, The Journal of Biological Chemistry.

[38]  S. Grissmer,et al.  Pharmacological Profiling of Orthochirus scrobiculosus Toxin 1 Analogs with a Trimmed N-Terminal Domain , 2006, Molecular Pharmacology.

[39]  S. Griffey,et al.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases , 2006, Proceedings of the National Academy of Sciences.

[40]  Z. Weng,et al.  ZDOCK predictions for the CAPRI challenge , 2003, Proteins.

[41]  Z. Qi,et al.  Structural and functional analysis of natrin, a venom protein that targets various ion channels. , 2006, Biochemical and biophysical research communications.

[42]  P. Calabresi,et al.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. , 2003, The Journal of clinical investigation.

[43]  P. Calabresi,et al.  Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. , 2004, Molecular pharmacology.

[44]  Yingliang Wu,et al.  Molecular mechanism of δ‐dendrotoxin–potassium channel recognition explored by docking and molecular dynamic simulations , 2011, Journal of molecular recognition : JMR.